How to Cite
Abstract
Female patient, 52 was diagnosed with PMP. In May 2018 was performed following cytoreduction, HIPEC was performed with closed abdominal technique. The chemotherapeutic agents were dissolved in 4.2 liters of perfusion solution to match the volume of the abdominal cavity, and intraperitoneal chemotherapy was administered at 41°C for 90 minutes. Mitomycin C was used in (12 mg/m2). Technical aspects of cytoreductive surgery by Sugarbaker: Right subdiaphragmatic and parietal peritonectomy, left subdiaphragmatic and parietal peritonectomy, omentectomy, pelvic cholecystectomy, appendectomy. Unfortunately, patient had developed recurrence after treatment in December 2018 and underwent repeated cytoreduction and HIPEC. We have described a case of a female patient who developed aggressive PMCA, with a misleading clinical presentation. There is no consensus regarding the proper management of aggressive cases. Recent studies support that cytoreduction with peritonectomy plus HIPEC is a safe procedure that suggests an improvement in the survival rates, even in aggressive cases.
References
Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003 Jul;12(3):585-603.
Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017 Aug;33(5):511-519.
Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008 Feb;34(2):196-201.
Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014 Jun;109(7):740-5.
Pallas N, Karamveri C, Kyziridis D, Hristakis C, Kyriakopoulos V, Kalakonas A, Vaikos D, Tentes AK. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis. J BUON. 2017 Nov-Dec;22(6):1547-1553.
Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology. 2017 Dec;71(6):847-858.